Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Galderma will acquire CollaGenex for $16.60 per share, or about $420 million in cash. The price is a 30% premium to CollaGenex’s close of $12.80 on Feb. 25, the day before the deal was announced. Gald...